Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database
(175)
Maurer, Britta
a
Graf, Nicole
b
Michel, Beat A
a
Müller Ladner, Ulf
c
Czirják, László
d
Denton, Christopher P
e
Tyndall, Alan
f
Metzig, Carola
g
Lanius, Vivian
g
Khanna, Dinesh
h
Distler, Oliver
a
Tarner, Ingo H
c
Cerinic, Marco Matucci
i
Guiducci, Serena
i
Walker, Ulrich
f
Lapadula, Giovanni
j
Iannone, Florenzo
j
Becvar, Radim
k
Sierakowsky, Stanislaw
l
Bielecka, Otylia Kowal
l
Cutolo, Maurizio
m
Sulli, Alberto
m
Valentini, Gabriele
n
Cuomo, Giovanna
n
Vettori, Serena
n
Riemekasten, Gabriele
o
Rednic, Simona
p
Nicoara, Ileana
p
Kahan, André
q
Allanore, Yannick
q
Vlachoyiannopoulos, P
r
Montecucco, C
s
Caporali, Roberto
s
Carreira, Patricia E
t
Novak, Srdan
u
Varju, Cecilia
d
Chizzolini, Carlo
v
Kucharz, Eugene J
w
Kotulska, Anna
w
Kopec Medrek, Magdalena
w
Widuchowska, Malgorzata
w
Cozzi, Franco
x
Rozman, Blaz
y
Mallia, Carmel
z
Coleiro, Bernard
z
Gabrielli, Armando
aa
Farge, Dominique
ab
Hij, Adrian
ab
Airò, Paolo
ac
Hesselstrand, Roger
ad
Scheja, Agneta
ad
Wollheim, Frank
ad
Martinovic, Duska
ae
Gurman, Alexandra Balbir
af
Braun Moscovici, Yolanda
af
Govoni, M
ag
Monaco, Andrea Lo
ag
Hunzelmann, Nicolas
ah
Pellerito, Raffaele
ai
Bambara, Lisa Maria
aj
Caramaschi, Paola
aj
Black, Carol
e
Damjanov, Nemanja
ak
Henes, Jörg
al
Santamaria, Vera Ortiz
am
Heitmann, Stefan
an
Krasowska, Dorota
ao
Seidel, Matthias
ap
Oleszowsky, Mara
ap
Burkhardt, Harald
aq
Himsel, Andrea
aq
Salvador, Maria J
ar
Stamenkovic, Bojana
as
Stankovic, Aleksandra
as
Tikly, Mohammed
at
Starovoytova, Maya N
au
Ananieva, Lidia P
au
Scorza, Raffaella
av
Engelhart, Merete
aw
Strauss, Gitte
aw
Nielsen, Henrik
aw
Damgaard, Kirsten
aw
Szücs, Gabriella
ax
Mendoza, Antonio Zea
ay
de la Puente Buijdos, Carlos
ay
Sifuentes Giraldo, Walter A
ay
Midtvedt, Øyvind
az
Garen, Torhild
az
Hachulla, Eric
ba
Launay, David
ba
Valesini, Guido
bb
Riccieri, Valeria
bb
Ionescu, Ruxandra Maria
bc
Opris, Daniela
bc
Groseanu, Laura
bc
Wigley, Fredrick M
bd
Mihai, Carmen M
be
Cornateanu, Roxana Sfrent
be
Ionitescu, Razvan
be
Gherghe, Ana Maria
be
Gorga, Marilena
be
Dobrota, Rucsandra
be
Bojinca, Mihai
be
Schett, Georg
bf
Distler, Jörg H W
bf
Meroni, Pierluigi
bg,bh
Zeni, Silvana
bg
Mouthon, Luc
q
De Keyser, Filip
bi
Smith, Vanessa
bi
Cantatore, Francesco P
bj
Corrado, Ada
bj
Ullman, Susanne
bk
Iversen, Line
bk
Pozzi, Maria R
bl
Eyerich, Kilian
bm
Hein, Rüdiger
bm
Knott, Elisabeth
bm
Szechinski, Jacek
bn
Wiland, Piotr
bn
Szmyrka Kaczmarek, Magdalena
bn
Sokolik, Renata
bn
Morgiel, Ewa
bn
Krummel Lorenz, Brigitte
bo
Saar, Petra
bo
Aringer, Martin
bp
Günther, Claudia
bp
Anic, Branimir
bq
Baresic, Marko
bq
Mayer, Miroslav
bq
Radominski, Sebastião C
br
de Souza Müller, Carolina
br
Azevedo, Valderílio F
br
Agachi, Svetlana
bs
Groppa, Liliana
bs
Chiaburu, Lealea
bs
Russu, Eugen
bs
Zenone, Thierry
bt
Stebbings, Simon
bu
Highton, John
bu
Stamp, Lisa
bv
Chapman, Peter
bv
O’Donnell, John
bw
Solanki, Kamal
bw
Doube, Alan
bw
Veale, Douglas
bx
O’Rourke, Marie
bx
Loyo, Esthela
by
Li, Mengtao
bz
Rosato, Edoardo
bb
Pisarri, Simonetta
ca
Tanaseanu, Cristina Mihaela
cb
Popescu, Monica
cb
Dumitrascu, Alina
cb
Tiglea, Isabela
cb
Chirieac, Rodica
cb
Ancuta, Codrina
cb
Furst, Daniel E
cc
Kafaja, Suzanne
cc
de la Peña Lefebvre, Paloma García
cd
Rubio, Silvia Rodriguez
cd
Exposito, Marta Valero
cd
Sibilia, Jean
ce
Chatelus, Emmanuel
ce
Gottenberg, Jacques Eric
ce
Chifflot, Hélène
ce
Litinsky, Ira
cf
Venalis, Algirdas
cg
Butrimiene, Irena
cg
Venalis, Paulius
cg
Rugiene, Rita
cg
Karpec, Diana
cg
Kerzberg, Eduardo
ch
Montoya, Fabiana
ch
Cosentino, Vanesa
ch
more..
|
-
1
-
-
0027729083
-
Skin thickness score in systemic sclerosis: An assessment of interobserver variability in 3 independent studies
-
Clements PJ, Lachenbruch PA, Seibold JR, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 1993;20:1892-6.
-
(1993)
J Rheumatol
, vol.20
, pp. 1892-1896
-
-
Clements, P.J.1
Lachenbruch, P.A.2
Seibold, J.R.3
-
2
-
-
77956631231
-
Evidence-based management of rapidly progressing systemic sclerosis
-
Khanna D, Denton CP. Evidence-based management of rapidly progressing systemic sclerosis. Best Pract Res Clin Rheumatol 2010;24:387-400.
-
(2010)
Best Pract Res Clin Rheumatol
, vol.24
, pp. 387-400
-
-
Khanna, D.1
Denton, C.P.2
-
3
-
-
0029048089
-
Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis
-
Clements P, Lachenbruch P, Siebold J, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995;22:1281-5.
-
(1995)
J Rheumatol
, vol.22
, pp. 1281-1285
-
-
Clements, P.1
Lachenbruch, P.2
Siebold, J.3
-
4
-
-
68049111578
-
Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: Analysis of three large multicenter, double-blind, randomized controlled trials
-
Amjadi S, Maranian P, Furst DE, et al. Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: analysis of three large multicenter, double-blind, randomized controlled trials. Arthritis Rheum 2009;60:2490-8.
-
(2009)
Arthritis Rheum
, vol.60
, pp. 2490-2498
-
-
Amjadi, S.1
Maranian, P.2
Furst, D.E.3
-
5
-
-
34547485497
-
Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: Application of a latent linear trajectory model
-
Shand L, Lunt M, Nihtyanova S, et al. Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model. Arthritis Rheum 2007;56:2422-31.
-
(2007)
Arthritis Rheum
, vol.56
, pp. 2422-2431
-
-
Shand, L.1
Lunt, M.2
Nihtyanova, S.3
-
6
-
-
34547743765
-
Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase i antibody
-
Perera A, Fertig N, Lucas M, et al. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody. Arthritis Rheum 2007;56:2740-6.
-
(2007)
Arthritis Rheum
, vol.56
, pp. 2740-2746
-
-
Perera, A.1
Fertig, N.2
Lucas, M.3
-
7
-
-
33847394965
-
Mycophenolate mofetil in diffuse cutaneous systemic sclerosis-a retrospective analysis
-
Nihtyanova SI, Brough GM, Black CM, et al. Mycophenolate mofetil in diffuse cutaneous systemic sclerosis-a retrospective analysis. Rheumatology (Oxford) 2007;46:442-5.
-
(2007)
Rheumatology (Oxford)
, vol.46
, pp. 442-445
-
-
Nihtyanova, S.I.1
Brough, G.M.2
Black, C.M.3
-
8
-
-
0033064099
-
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: Analysis of a two-year, double-blind, randomized, controlled clinical trial
-
Clements PJ, Furst DE, Wong WK, et al. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial. Arthritis Rheum 1999;42:1194-203.
-
(1999)
Arthritis Rheum
, vol.42
, pp. 1194-1203
-
-
Clements, P.J.1
Furst, D.E.2
Wong, W.K.3
-
9
-
-
65249109216
-
Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: A randomized, double-blind, placebo-controlled trial
-
Khanna D, Clements PJ, Furst DE, et al. Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2009;60:1102-11.
-
(2009)
Arthritis Rheum
, vol.60
, pp. 1102-1111
-
-
Khanna, D.1
Clements, P.J.2
Furst, D.E.3
-
10
-
-
33750367940
-
Minimally important difference in diffuse systemic sclerosis: Results from the D-penicillamine study
-
Khanna D, Furst DE, Hays RD, et al. Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study. Ann Rheum Dis 2006;65:1325-9.
-
(2006)
Ann Rheum Dis
, vol.65
, pp. 1325-1329
-
-
Khanna, D.1
Furst, D.E.2
Hays, R.D.3
-
11
-
-
0034970031
-
A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma
-
Pope JE, Bellamy N, Seibold JR, et al. A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma. Arthritis Rheum 2001;44:1351-8.
-
(2001)
Arthritis Rheum
, vol.44
, pp. 1351-1358
-
-
Pope, J.E.1
Bellamy, N.2
Seibold, J.R.3
-
12
-
-
84863857123
-
Update on the profile of the EUSTAR cohort: An analysis of the EULAR Scleroderma Trials and Research group database
-
Meier FM, Frommer KW, Dinser R, et al. Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 2012;71:1355-60.
-
(2012)
Ann Rheum Dis
, vol.71
, pp. 1355-1360
-
-
Meier, F.M.1
Frommer, K.W.2
Dinser, R.3
-
13
-
-
0018887574
-
Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee
-
Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
-
(1980)
Arthritis Rheum
, vol.23
, pp. 581-590
-
-
-
15
-
-
0042386341
-
European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score
-
Valentini G, D'Angelo S, Della Rossa A, et al. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score. Ann Rheum Dis 2003;62:904-5.
-
(2003)
Ann Rheum Dis
, vol.62
, pp. 904-905
-
-
Valentini, G.1
D'angelo, S.2
Della Rossa, A.3
-
16
-
-
34248379222
-
Clinical risk assessment of organ manifestations in systemic sclerosis: A report from the EULAR Scleroderma Trials and Research group database
-
Walker UA, Tyndall A, Czirjak L, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 2007;66:754-63.
-
(2007)
Ann Rheum Dis
, vol.66
, pp. 754-763
-
-
Walker, U.A.1
Tyndall, A.2
Czirjak, L.3
-
17
-
-
78650663333
-
Skin thickness progression rate: A predictor of mortality and early internal organ involvement in diffuse scleroderma
-
Domsic RT, Rodriguez-Reyna T, Lucas M, et al. Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma. Ann Rheum Dis 2011;70:104-9.
-
(2011)
Ann Rheum Dis
, vol.70
, pp. 104-109
-
-
Domsic, R.T.1
Rodriguez-Reyna, T.2
Lucas, M.3
-
18
-
-
0033767899
-
Severe organ involvement in systemic sclerosis with diffuse scleroderma
-
Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000;43:2437-44.
-
(2000)
Arthritis Rheum
, vol.43
, pp. 2437-2444
-
-
Steen, V.D.1
Medsger, T.A.2
-
19
-
-
73849094087
-
Assessing the performance of prediction models: A framework for traditional and novel measures
-
Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 2010;21:128-38.
-
(2010)
Epidemiology
, vol.21
, pp. 128-138
-
-
Steyerberg, E.W.1
Vickers, A.J.2
Cook, N.R.3
-
20
-
-
77954436578
-
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: Results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database
-
Avouac J, Walker U, Tyndall A, et al. Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol 2010;37:1488-501.
-
(2010)
J Rheumatol
, vol.37
, pp. 1488-1501
-
-
Avouac, J.1
Walker, U.2
Tyndall, A.3
-
21
-
-
84863469731
-
Patterns and predictors of change in outcome measures in clinical trials in scleroderma: An individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosis
-
Merkel PA, Silliman NP, Clements PJ, et al. Patterns and predictors of change in outcome measures in clinical trials in scleroderma: an individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosis. Arthritis Rheum 2012;64:3420-9.
-
(2012)
Arthritis Rheum
, vol.64
, pp. 3420-3429
-
-
Merkel, P.A.1
Silliman, N.P.2
Clements, P.J.3
-
22
-
-
73249139173
-
Rapamycin versus methotrexate in early diffuse systemic sclerosis: Results from a randomized, single-blind pilot study
-
Su TI, Khanna D, Furst DE, et al. Rapamycin versus methotrexate in early diffuse systemic sclerosis: results from a randomized, single-blind pilot study. Arthritis Rheum 2009;60:3821-30.
-
(2009)
Arthritis Rheum
, vol.60
, pp. 3821-3830
-
-
Su, T.I.1
Khanna, D.2
Furst, D.E.3
|